Literature DB >> 15747979

Telepresence and telemedicine in trauma and emergency care management.

Rifat Latifi1, Kim Peck, John M Porter, Ron Poropatich, Ted Geare, Richard B Nassi.   

Abstract

The use of telemedicine is long-standing, but only recently has been applied to the specialties of trauma, emergency care, and surgery. Subsequently the concepts of teletrauma, telepresence, and telesurgery have evolved and are being integrated into modern care of trauma and surgical patients. This chapter will review the current applications and future endeavors of telemedicine and telepresence to trauma and emergency care as the new frontiers of telemedicine application.

Entities:  

Mesh:

Year:  2004        PMID: 15747979

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  5 in total

1.  Video conferencing versus telephone calls for team work across hospitals: a qualitative study on simulated emergencies.

Authors:  Stein R Bolle; Frank Larsen; Oddvar Hagen; Mads Gilbert
Journal:  BMC Emerg Med       Date:  2009-11-30

2.  Virtual Interactive Presence in Global Surgical Education: International Collaboration Through Augmented Reality.

Authors:  Matthew Christopher Davis; Dang D Can; Jonathan Pindrik; Brandon G Rocque; James M Johnston
Journal:  World Neurosurg       Date:  2015-09-03       Impact factor: 2.104

3.  Robotic telepresence in the intensive care unit.

Authors:  Paul Vespa
Journal:  Crit Care       Date:  2005-06-16       Impact factor: 9.097

4.  Usefulness of videoconferencing in psychiatric emergencies -- a qualitative study.

Authors:  Stein Roald Bolle; Marianne Vibeke Trondsen; Geir Øyvind Stensland; Aksel Tjora
Journal:  Health Technol (Berl)       Date:  2017-03-24

Review 5.  Image-based medical expert teleconsultation in acute care of injuries. A systematic review of effects on information accuracy, diagnostic validity, clinical outcome, and user satisfaction.

Authors:  Marie Hasselberg; Netta Beer; Lisa Blom; Lee A Wallis; Lucie Laflamme
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.